Results 261 to 270 of about 947,807 (342)

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology, Volume 20, Issue 9, Page 2135-2162, September 2026.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer   +7 more
wiley   +1 more source

Mesonephric-Like Adenocarcinoma of the Endometrium and the Impact of the Updated 2023 FIGO Staging System. [PDF]

Case Rep Obstet Gynecol
Ogunmuyiwa J, Hamilton A, Hayek J, Ogunmuyiwa J, Gorelick C, Levitan D, Ashamalla H.   +6 more
europepmc   +1 more source

Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy

The Journal of Pathology: Clinical Research, Volume 12, Issue 5, September 2026.
Abstract NTRK fusions drive the pathogenesis of a distinctive group of mesenchymal neoplasms with significant impact on classification and targeted therapy. However, unexpected NTRK fusions have been reported in other sarcoma entities, raising uncertainty over their specificity and clinical management.
Mohamed A Yakoub, Purvil Sukhadia, Carla Saoud, Meera Hameed, Cristina R Antonescu   +4 more
wiley   +1 more source

Lymphoma of the cervix invading the uterine body with distant lymphadenopathy: MRI and FDG-PET/CT findings. [PDF]

Radiol Case Rep
Vu I, Vu P, Byun T, Stelling A.
europepmc   +1 more source

Fisetin Attenuates Uterine Leiomyoma in Rats: Potential Crosstalk Between HMGB1, SphK1/S1P, and TGF-β Signaling. [PDF]

J Biochem Mol Toxicol
Maghraby N, Khalaf E, Hussien MT, Sobh AMA, Elmelegy NT.   +4 more
europepmc   +1 more source

Expression of melanocytic markers in uterine smooth muscle tumours. [PDF]

Histopathology
Mirzabeigi Y, Abulaban A, Bahmad HF, Schlumbrecht MP, Pinto A.   +4 more
europepmc   +1 more source

<i>KAT6B/A::KANSL1</i> uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model. [PDF]

Gynecol Oncol Rep
Chen L, Liu J, Nechala I, Praveen Kumar P, Ewanowich C, Levecchia M, Aubrey C, Fu Y, Lee CH.   +8 more
europepmc   +1 more source

Rescuing a refractory Leiomyosarcoma: ALK-DCTN1 fusion as a gateway to long-term control with Ceritinib. [PDF]

Gynecol Oncol Rep
Tieng FYF, Subramaniam SK, Ooi PL.
europepmc   +1 more source

Giant Primary Ovarian Leiomyoma Mimicking Ovarian Malignancy in an Elderly Postmenopausal Woman: A Rare Case Report. [PDF]

Clin Case Rep
Lugata J, Batchu N, Mrosso O, Kabuhaya J, Pinches E, Maringo G, Maro E, Mchome B, Mremi A.   +8 more
europepmc   +1 more source

Abstracts from the 2026 Congress of the Scandinavian Society of Anesthesiology and Intensive Care Medicine, Reykjavik, Iceland, June 10–12, 2026

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.
wiley   +1 more source